Microbial Production of 3,4-Dihydroxybutyrate (DHBA) and 3-Hydroxybutyrolactone (3-HBL) from Glucose
Invention type: Technology
/
Case number: #14595
The invention relates to recombinant cells and their use in the production of 3,4-dihydroxybutyrate, 2,3-dihydroxybutyrate and 3-hydroxybutyrolactone.
Researchers
Kristala L Jones Prather
/
Himanshu Dhamankar
/
Collin Martin
Departments: Department of Chemical Engineering
Technology Areas: Chemicals & Materials: Catalysis & Synthesis / Computer Science: Bioinformatics / Drug Discovery and Research Tools: Genomics & Proteomics
Impact Areas: Healthy Living
-
microbial production of 3,4-dihydroxybutyrate (3,4-dhba), 2,3- dihydroxybutyrate (2,3-dhba) and 3-hydroxybutyrolactone (3-hbl)
United States of America | Granted | 8,669,379
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.